Board of Directors
Ian Paling - Executive Chairman and CEO.
Ian's background is in orthopaedics. From 1994 to 2007, Ian was the CEO of Corin Group PLC which, under his leadership grew to a highly regarded publicly quoted orthopaedic company with a world leading position in hip resurfacing.Prior to joining Corin, Ian, who has a B.Sc. and M.Sc. in metallurgy, worked for ten years in senior management roles for several OEM suppliers of orthopaedic devices. He is currently a Non Executive Director of Metalrax PLC, and a Non Executive Director of Sphere Medical Holding PLC
Dr Jens Riesle - Chief Scientific Officer and Executive Director
Jens is an expert in the scientific and product development aspects of knee cartilage repair with more than 13 years experience in the industry. He was the Co-Founder and CEO of CellCoTec BV and is currently Chief Scientific Officer. Prior to this, he was Group Leader, Cartilage Repair for IsoTis SA. Jens received his PhD at the Max Planck Institute for Biochemistry in 1996. He also carried out postdoctoral work on tissue-engineered cartilage at the Massachusetts Institute of Technology.
Professor Clemens van Blitterswijk - Non Executive Director
Clemens is Professor of Regenerative Medicine at Twente University in the Netherlands. He has authored and co-authored over 200 scientific papers, is named inventor on numerous patents and frequently acts as an invited speaker or chairman at international conferences. During his career, he has co-founded four biomedical companies. He was the CEO of IsoTis NV from 1996 to 2002. He currently sits on several advisory bodies relating directly to life and material sciences and he is a non-executive board member of Progentix BV, River Diagnostics BV, and Polyganics BV.
Dr Jaap Kampinga - Non Executive Director
Jaap began his career as a medical doctor and academic scientist in 1984 after obtaining a medical degree from the University of Groningen. Jaap has previously held senior positions with Quadrant Healthcare plc, JARI Pharmaceuticals BV and PhotoBioChem NV. In 2003, he became a managing director of Oakes, Lyman & Co. Limited, a firm specialising in structuring, building, and financing medical businesses.
Dr Jeanine Hendriks - Director of Product Development
Jeanine was one of the co- founders of CellCoTec BV in 2004. It was her insight that led to the discovery of how to instruct chondrocytes to form strong cartilage material under controlled conditions. Prior to CellCoTec, she was a group leader cartilage product development at IsoTis SA and was responsible for the launch of a first generation ACI product. She is well published, having written or co-authored several publications and articles in the field of cartilage repair and regeneration with more than 16 years of experience in cell and developmental biology research and 10 years of experience in cartilage product development. Dr Hendriks' PhD is from the University of Twente, the Institute of Biomechanical Technology.
Howard Miller - Chief Financial Officer and Executive Director
Howard's background is in life science finance and research. From 2000 to 2007, Howard was a Life Science Equity Analyst at UK broker Teather & Greenwood, becoming Head of Research in 2004. During this period, Howard worked on the flotation’s of a number of life science companies and provided equity research on UK listed large and small cap medical businesses. In 2007, Howard joined Oakes, Lyman & Co. Limited, working with their portfolio of private medical device companies, including CellCoTec, on financing and strategy. He was appointed Acting CFO of CellCoTec in 2009 and joined the company full time as Chief Financial Officer in 2010.